MOLLY CONLIN: Open Payments
NPI 1669944203 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 23 payments from 11 companies in 2025. Trend: 2023 $286 · 2024 $603 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $150 |
| GENZYME CORPORATION | 2 | $57 |
| Lilly USA, LLC | 3 | $57 |
| ABBVIE INC. | 3 | $55 |
| Janssen Biotech, Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Intercept Pharmaceuticals, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
Products named: ENTYVIO, DUPIXENT, OMVOH, TREMFYA, VOQUEZNA, OCALIVA, GATTEX, IBSRELA.
Industry payments across DE — which companies pay providers there.
